145 related articles for article (PubMed ID: 6808441)
1. The unspecific antibody response to N. meningitidis group A capsular polysaccharide often seen in bacteraemic diseases.
Käyhty H
Parasite Immunol; 1982 May; 4(3):157-70. PubMed ID: 6808441
[TBL] [Abstract][Full Text] [Related]
2. Antibody response to capsular polysaccharides of groups A and C neisseria meningitidis and Haemophilus influenzae type b during bacteremic disease.
Käyhty H; Jousimies-Somer H; Peltola H; Mäketä PH
J Infect Dis; 1981 Jan; 143(1):32-41. PubMed ID: 6783703
[TBL] [Abstract][Full Text] [Related]
3. Interim report of a controlled field trial of immunization with capsular polysaccharides of Haemophilus influenzae type b and group C Neisseria meningitidis in Mecklenburg county, North Carolina (March 1974-March 1976).
Parke JC; Schneerson R; Robbins JB; Schlesselman JJ
J Infect Dis; 1977 Aug; 136 Suppl():S51-6. PubMed ID: 408433
[TBL] [Abstract][Full Text] [Related]
4. Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
Weinberg GA; Einhorn MS; Lenoir AA; Granoff PD; Granoff DM
J Pediatr; 1987 Jul; 111(1):22-7. PubMed ID: 3110388
[TBL] [Abstract][Full Text] [Related]
5. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
Jennings HJ
Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
[No Abstract] [Full Text] [Related]
6. Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses.
Tarkowski A; Lue C; Moldoveanu Z; Kiyono H; McGhee JR; Mestecky J
J Immunol; 1990 May; 144(10):3770-8. PubMed ID: 2110213
[TBL] [Abstract][Full Text] [Related]
7. Comparative immunogenicity of vaccines prepared from capsular polysaccharides of group C Neisseria meningitidis O-acetyl-positive and O-acetyl-negative variants and Escherichia coli K92 in adult volunteers.
Glode MP; Lewin EB; Sutton A; Le CT; Gotschlich EC; Robbins JB
J Infect Dis; 1979 Jan; 139(1):52-9. PubMed ID: 108338
[TBL] [Abstract][Full Text] [Related]
8. An enzyme-linked immunosorbent assay for quantitation of Haemophilus Influenzae type b polysaccharide-specific IgG1 and IgG2 in human and infant rhesus monkey sera.
Dolan KT; Staub JM; Schofield TL; Ahonkhai VI; Ellis RW; Vella PP
J Immunoassay; 1991; 12(4):543-64. PubMed ID: 1806588
[TBL] [Abstract][Full Text] [Related]
9. The immunogenicity of Hemophilus influenzae type B polysaccharide-Neisseria meningitidis group B outer membrane protein complex vaccine in infants and young children.
Shapiro ED; Capobianco LA; Berg AT; Zitt MQ
J Infect Dis; 1989 Dec; 160(6):1064-7. PubMed ID: 2511254
[TBL] [Abstract][Full Text] [Related]
10. Persistence of antibodies to meningococcal IgA1 protease versus decay of antibodies to group A polysaccharide and Opc protein.
Thiesen B; Greenwood B; Brieske N; Achtman M
Vaccine; 1997 Feb; 15(2):209-19. PubMed ID: 9066040
[TBL] [Abstract][Full Text] [Related]
11. Increase in titers of antibodies to Mycoplasma pneumoniae in patients with purulent meningitis.
Kleemola M; Käyhty H
J Infect Dis; 1982 Aug; 146(2):284-8. PubMed ID: 6809846
[TBL] [Abstract][Full Text] [Related]
12. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
Sood SK; Daum RS
Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
[TBL] [Abstract][Full Text] [Related]
13. Human immune responses to polysaccharide antigens: an analysis of bacterial polysaccharide vaccines in infants.
Barrett DJ
Adv Pediatr; 1985; 32():139-58. PubMed ID: 3909772
[TBL] [Abstract][Full Text] [Related]
14. Opsonophagocidal activity in sera from infants and children immunized with Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate).
Gray BM
Pediatrics; 1990 Apr; 85(4 Pt 2):694-7. PubMed ID: 2107521
[TBL] [Abstract][Full Text] [Related]
15. Immune response of infants and children to disseminated infections with Neisseria meningitidis.
Griffiss JM; Brandt BL; Broud DD; Goroff DK; Baker CJ
J Infect Dis; 1984 Jul; 150(1):71-9. PubMed ID: 6431015
[TBL] [Abstract][Full Text] [Related]
16. Conjugated polysaccharide vaccines.
Ahmad H; Chapnick EK
Infect Dis Clin North Am; 1999 Mar; 13(1):113-33, vii. PubMed ID: 10198795
[TBL] [Abstract][Full Text] [Related]
17. Serum antibodies to capsular polysaccharide vaccine of group A and C Neisseria meningitidis in military recruits in Italy.
Occhionero M; Usai G; Di Martino M; Le Moli S; Stroffolini T; Mastrantonio P
Allergol Immunopathol (Madr); 1991; 19(1):39-41. PubMed ID: 1950941
[TBL] [Abstract][Full Text] [Related]
18. Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland.
Mäkelä PH; Peltola H; Käyhty H; Jousimies H; Pettay O; Ruoslahti E; Sivonen A; Renkonen OV
J Infect Dis; 1977 Aug; 136 Suppl():S43-50. PubMed ID: 408432
[No Abstract] [Full Text] [Related]
19. Class-specific human bactericidal antibodies to capsular and noncapsular surface antigens of Neisseria meningitidis.
Skevakis L; Frasch CE; Zahradnik JM; Dolin R
J Infect Dis; 1984 Mar; 149(3):387-96. PubMed ID: 6425422
[TBL] [Abstract][Full Text] [Related]
20. Dose-related immunogenicity of Haemophilus influenzae type b capsular polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
Wong VK; Quagliata R; Adler R; Kim KS
Am J Dis Child; 1991 Jul; 145(7):742-5. PubMed ID: 2058604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
